Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt.

• Hauptverfasser: Haidi Karam-Allah Ramadan (Verfasst von), Waleed Attia Hassan (Verfasst von), Nahed Ahmed Elossily (Verfasst von), Alzahraa Abdelraouf Ahmad (Verfasst von), Adnan Ahmed Mohamed (Verfasst von), Alaa Soliman Abd-Elkader (Verfasst von), Eman M Nagiub Abdelsalam (Verfasst von), Hani M J Khojah (Verfasst von)
• Format: Buch
• Veröffentlicht: Public Library of Science (PLoS), 2019-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

<h4>Background</h4>Fascioliasis is a neglected zoonosis with major public health implications in humans. Although triclabendazole (TCBZ) is the drug of choice, there are records of TCBZ failure worldwide. TCBZ-resistant fascioliasis is treated with alternative approved drugs including ni...